SDGR · Schrodinger, Inc. · Metrics
$29.80
+5.87 (+24.53%)
At close · Sep 17
Market Cap
$1.73B
Shares
74.81M
SDGR metrics
69 of 115 screener metrics currently available.
Market overview
2 metricsShare price
$23.93
Market cap
$1.73B
Price action
20 metricsPrice change (1W)
+24.6%
Price change (30D)
+35.4%
Price change (3M)
+54.1%
Price change (6M)
+99.7%
Price change (YTD)
+33.8%
Price change (1Y)
+25.2%
Trailing year
Price change (5Y)
-60.9%
52-week high
$23.93
52-week low
$11.07
Change from 52-week high
+0.0%
Change from 52-week low
+116.2%
Annualized volatility
56.5%
Annualized volatility (3M)
60.7%
Beta
1.6
RSI (14D)
72.7
Price vs SMA 50
+33.6%
Price vs SMA 200
+57.1%
Avg volume (3M)
1.24M
Relative volume
2.3
Average dollar volume
$22.14M
Company
3 metricsSector
Healthcare
Industry
Health Information Services
Shares outstanding
74.81M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
6.7×
reciprocal yield 15.0%
P / book
5.2
reciprocal yield 19.1%
FCF yield
-7.5%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-3.1%
Historical valuation
8 metricsP / E historical average (3Y)
96.8×
reciprocal yield 1.0%
P / E historical average (5Y)
96.8×
reciprocal yield 1.0%
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-08-05
Profitability
9 metricsGross margin
56.9%
Operating margin
-59.2%
Trailing 12 months
Net margin
-21.0%
Gross profit (TTM)
$147.31M
Operating profit (TTM)
−$153.44M
Net income (TTM)
−$54.34M
Trailing 12 months
Diluted EPS (TTM)
$-0.73
FCF margin
-50.3%
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
+7.5%
Year over year
Net income growth YoY
—
Revenue (TTM)
$259.04M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+3.2%
Year over year · more shares
Revenue CAGR (3Y)
+12.2%
Revenue CAGR (5Y)
+18.8%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
-2.6%
Quality
14 metricsReturn on equity
-16.5%
Return on assets
-8.5%
Debt / equity
—
Current ratio
2.7
EBITDA (TTM)
−$147.58M
Free cash flow (TTM)
−$130.27M
Quick ratio
2.7
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$413.74M
Latest balance sheet
Cash & equivalents
$287.85M
Total assets
$640.39M
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$126.87M
Capital expenditures (TTM)
$3.40M
R&D (TTM)
$168.98M
SG&A (TTM)
—
Stock compensation (TTM)
$38.66M
R&D / revenue
65.2%
Stock compensation / revenue
14.9%
Ownership (13F)
3 metrics13F filers
233
13F filer change QoQ
+2
Institutional ownership
87.8%
Short interest
3 metricsShort interest
14.8%
Latest settlement · 11.8 days to cover
Days to cover
11.8d
Short-squeeze score
98 / 100
Insider activity
2 metricsNet insider buying (90D)
−$13,647
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—
Key facts
CIK
1490978
CUSIP
80810D103
13F (30d)
12 filings
12 filers
Visit website
Investor relations